Generate:Biomedicines @generate_biomed Twitter profile

Last Seen Profiles

@LeeRunas

@hugoraffael

@ParksRecords

@ODFoundation

@shuji24hr

@SoCalBirds

@ember1449

@baby_girl_ola

@EmmelynArt

@PkmnAfricanus

@DrDickSexAdvce

@ATLFalconsUK

@BlueR00n

@jennnnarose

@realrockriley

@beeu7777

@yukimusiii

@cry2ana

@144_george

@LisaGarvo

@KurtBenkert

@YIRENxUP

@veltjs

@MrJerryOC

@BakbakEnt

@TrishaMellon

@i_shintaro

@NitanshuL

@imorasihunigi95

@interrobange

@HumbleISD_KHS

@yodominguez

@SpiritofourLord

@himari_nohira

@NCAR_Science

Generate:Biomedicines

@generate_biomed

1 year

Today we introduced Chroma, a generative model that creates new proteins & protein complexes given geometric & functional constraints. It learns to transform unstructured, random 3D shapes into #protein molecules, which can have tens of thousands of atoms.

13

231

1K

Generate:Biomedicines

@generate_biomed

6 months

Today we release Chroma, our generative model for protein design, open-source on Github with a Nature publication describing its biophysical and crystallographic validation. Chroma Conditioners enable one model to target multiple protein design objectives.

2

77

274

Generate:Biomedicines

@generate_biomed

1 year

Our new machine learning model, Chroma, can generate extremely large and intricate proteins and #protein complexes in just a few minutes. Read the preprint on @biorxivpreprint and learn about our breakthrough in protein #science : #ProteinEngineering

1

31

150

Generate:Biomedicines

@generate_biomed

6 months

Nearly all existing protein-based therapeutics are created from a fraction of possible protein concepts. This is about to change. We are excited to share a publication in @Nature describing Chroma, an AI model that can program novel proteins.

0

38

124

Generate:Biomedicines

@generate_biomed

10 months

Today, we announced the opening of our 70K sq ft CryoEM lab in Andover, Mass – among the largest privately owned labs of its kind in the U.S. – which will help drive faster and more efficient therapeutic development. Take an up-close look at the space:

1

11

74

Generate:Biomedicines

@generate_biomed

10 months

As Pride Month comes to a close, we wanted to share this photo of Team Generate wearing freshly tie-dyed G:Pride shirts. Thanks again to our LGBTQ+ Affinity Group & Fun Committee, who invited us to celebrate inclusivity & add a vibrant touch to our fiercely united organization.

0

8

64

Generate:Biomedicines

@generate_biomed

1 year

We are excited to share Chroma with the scientific community. As a next step, we’ll be submitting the technology that underlies Chroma for peer review. We look forward to enabling access to this model - stay tuned for more.

0

7

70

Generate:Biomedicines

@generate_biomed

1 year

We're pleased to be an attending sponsor of the Machine Learning for Structural Biology Workshop at the 36th @NeurIPSConf . This workshop brings together academia and industry experts to advance the impact of #machinelearning in structural biology:

2

11

61

Generate:Biomedicines

@generate_biomed

2 years

This morning we announced our first external financing, raising $370M in a #SeriesB . We're thrilled to welcome a world-class group of investors to our syndicate. #financing #innovation #machinelearning

1

10

57

Generate:Biomedicines

@generate_biomed

1 year

Proteins design is rapidly evolving as a result of recent advancements in diffusion models and generative AI. Our Head of Machine Learning John Ingraham covers this topic & more in an interview w/ @cenmag :

Generative AI is dreaming up new proteins

Move over, chatbots and image generation. AI-powered protein design is having a moment

cen.acs.org

0

15

50

Generate:Biomedicines

@generate_biomed

4 months

Want to be part of a revolution? Our Machine Learning summer internship is calling. We're seeking passionate innovators who are driven to make an impact on human health. Your opportunity starts here:

1

11

51

Generate:Biomedicines

@generate_biomed

8 months

Thank you @Nasdaq for highlighting our Series C funding raise in Times Square. What a great way to cap off such a momentous week for our company.

0

2

38

Generate:Biomedicines

@generate_biomed

1 year

Today, we released a preprint describing our #machinelearning model Chroma, which further validates our platform & capabilities. Learn how this breakthrough in protein #science opens a world of possibilities for future therapeutic treatments: #TeamGenerate

0

10

38

Generate:Biomedicines

@generate_biomed

2 years

Breaking news: We've just been named to @Forbes AI 50 List, which recognizes standout companies making the most interesting and effective use of artificial technology. #ForbesAI50

The AI 50 2023

Now in its fifth year, our annual list, produced in partnership with Sequoia and Meritech Capital, recognizes the most promising privately-held companies building businesses out of artificial...

www.forbes.com

2

5

35

Generate:Biomedicines

@generate_biomed

8 months

Today we announced that we raised $273 million in Series C financing to advance our preclinical & clinical pipeline. We’re proud to have the confidence of our investors, including all Series B investors, who believe we are revolutionizing drug development:

0

6

35

Generate:Biomedicines

@generate_biomed

2 years

Generate Biomedicines is partnering with @Amgen to leverage Generate’s pioneering #generativebiology platform to create life-saving #protein Tx. The agreement has a potential transaction value of $1.9 billion plus future royalties. Read more #AI

0

6

34

Generate:Biomedicines

@generate_biomed

1 year

Live from #JPM23 : Watch @bradloncar 's interview with our CEO, @mike_nally , to hear how we're moving from an artisanal craft of drug discovery to an engineerable endeavor by leveraging AI to computationally generate proteins, at scale, to create novel therapeutics.

Brad Loncar

@bradloncar

1 year

📽️ @generate_biomed 's @mike_nally helps me wrap my human brain around how AI and machine learning might impact drug development in the future. It's a buzzy area, I'm trying to learn the substance behind it. #JPM23

8

10

65

0

2

25

Generate:Biomedicines

@generate_biomed

2 years

What an exciting way to mark our 4th birthday! This morning we were named to @FierceBiotech 's Fierce 15 list that highlights companies that are poised to change the face of the industry. Read more here:

0

5

28

Generate:Biomedicines

@generate_biomed

2 years

Proud to have our CTO, Gevorg Grigoryan, presenting at the premier conference, @icmlconf , for #machinelearning . #icml2022 #AI #GenerativeBiology #ProteinDesign

0

2

25

Generate:Biomedicines

@generate_biomed

1 year

According to @NatureBiotech , $1.37 billion was invested in generative AI companies in 2022. With the advancements of breakthrough AI tools, including our model Chroma, it’s clear that a revolution in drug development is here. Read more:

0

3

24

Generate:Biomedicines

@generate_biomed

1 year

How is #AI going to transform biology? During an @endpts panel at #JPM23 , our CMO will join @AKAarsalan and other industry experts to share how AI will bring new medicines to patients faster and better tailored to their specific conditions. #PatientFocusedDrugDevelopment

Register for the livestream event

endpts.com

0

4

25

Generate:Biomedicines

@generate_biomed

2 years

At Generate we are able to infer generalizable principles by applying #machinelearning to the data we generate & produce models that are more performant. Learn more about what it's like to work at Generate from Gevorg Grigoryan, Co-Founder & CTO. #generativebiology #AWS #reInvent

0

7

25

Generate:Biomedicines

@generate_biomed

2 years

Generate is honored to receive the 2021 @Citeline_Awards Award for Most Innovative Start-Up Company -- a strong vote of confidence in our pioneering role in the field of generative biology to revolutionize drug discovery. #AI #machinelearning #startup #innovation

0

2

21

Generate:Biomedicines

@generate_biomed

1 year

Yesterday, we had the privilege to chat with Nobel laureate and our BOD member, @francesarnold . It was inspiring to hear her reflect on this moment for generative AI and how we can leverage it to solve significant problems in medicine and beyond.

0

23

Generate:Biomedicines

@generate_biomed

2 years

Frank Poelwijk talks about the dynamic, multidisciplinary team we've assembled. Interested in joining his group? Learn more about 2 positions: Scientist I/II Chemical Engineering and Principal Scientist/Assoc. and Director Quantitative HTP Experimentation:

0

2

22

Generate:Biomedicines

@generate_biomed

2 years

#ICYMI : Watch @NoubarAfeyan at #CodeCon share how instead of discovering biologic drugs, we're computer-generating them in an attempt to bring medicines to patients faster, cheaper, and better tailored to their specific conditions. #FlagshipFounded

1

6

23

Generate:Biomedicines

@generate_biomed

2 years

It's time for the 2nd installment in a series of articles from members of the Generate team who have been at the forefront of #generativebiology . Hear from our own @gibsmk , @AndrewLBeam , and Gevorg Grigoryan about the potential impact of #generativebiology

Introducing Generative Biology Part II: On the Brink of Transforming Drug Discovery

By Andrew Beam, Ph.D.

www.linkedin.com

0

5

21

Generate:Biomedicines

@generate_biomed

5 months

On Friday, our Co-Founder & CTO @ggrigoryanv will present at the Machine Learning in Structural Biology Workshop during @NeurIPSConf . Gevorg will discuss our recent @Nature publication describing Chroma, our generative protein model. Learn more:

0

2

21

Generate:Biomedicines

@generate_biomed

3 years

Thanks to @BusinessInsider and @rtnarch for recognizing @generate_biomed as one of the top biotech companies to watch over the next year. Generate is pioneering #GenerativeBiology and unlocking new medicines that will be more effective and available faster than ever before.

Business Insider

@BusinessInsider

3 years

Meet the 24 biotech startups that top VCs say are poised to take off in the next 12 months

1

8

21

0

5

22

Generate:Biomedicines

@generate_biomed

11 months

We’re pleased to announce that Dr. Alex Snyder has been named EVP of R&D. In her new role, Dr. Snyder will leverage her extensive clinical & scientific experience to accelerate our early-to-late-stage clinical pipeline of lifesaving medicines. Read more:

0

3

21

Generate:Biomedicines

@generate_biomed

1 year

In this @NatureBiotech article, @neilsavagewrite discusses how language models like ChatGPT could support new therapeutics. Our Professor in Residence @AndrewLBeam points out that other techniques, such as diffusion models, may be a more direct path.

0

5

21

Generate:Biomedicines

@generate_biomed

9 months

In an article in @FortuneMagazine , @PauloConfinfo asks, who's the next Moderna? Our own @mike_nally @gibsmk share why Generative AI will transform the industry and lead to novel therapies generated reliably, predictably, & instantaneously:

For Flagship, Moderna’s COVID-19 vaccine is a tough act to follow

A brashly confident biotech VC firm seeks the next world-changing company.

fortune.com

1

20

Generate:Biomedicines

@generate_biomed

7 months

Today, @NoubarAfeyan , our Co-founder & Board Chair, presented John Ingraham, Head of ML, w/ the Inaugural Chairman’s Award, which celebrates Generators who answer daring what if questions. John embodies this award daily by applying AI & ML to the field of protein engineering.

0

3

20

Generate:Biomedicines

@generate_biomed

1 year

Through our new collaboration with @MDAndersonNews , we aim to harness the power of The Generate Platform to create optimized, potentially best-in-class oncology therapeutics that can rapidly advance into proof-of-concept trials. Learn more:

0

6

19

Generate:Biomedicines

@generate_biomed

1 year

As part of @Women_Wearables ' goal to support and empower women in tech, @gibsmk did an interview to share her perspective, highlighting the women who inspire her and where her passion for innovating at the intersection of machine learning and biology began. Read her story.

WoW Woman in BioTech I Molly Gibson, Ph.D.

womenofwearables.com

0

3

19

Generate:Biomedicines

@generate_biomed

1 year

We're pleased to announce new data published in @FrontiersIn , in partnership with @DanaFarber , demonstrating our capability to computationally design and control protein space, to potentially reduce the effects of pre-existing immunity to biotherapeutics:

0

1

18

Generate:Biomedicines

@generate_biomed

1 year

Live from #JPM23 : Our CEO, @mike_nally , spoke with @NYSE to share how our ability to program and create new proteins will have revolutionary implications for developing novel therapeutics, which will ultimately transform human health. #TheCure (ious) #AI #ML #ProteinEngineering

NYSE 🏛

@NYSE

1 year

#TheCure (ious) sneak peak: @mike_nally of @generate_biomed is “applying technology to science to help us understand biology in ways the human mind never could.” One spark of curiosity can lead to cures of the world’s greatest challenges.

1

8

46

0

3

17

Generate:Biomedicines

@generate_biomed

2 years

We are seeking CAR-T and immuno-oncology scientists! Work at the frontiers of drug discovery, biology, and engineering to design novel T cell-directed therapies. Learn more at #GenerativeBiology #AI #cartcelltherapy #AntibodyEngineering

0

3

16

Generate:Biomedicines

@generate_biomed

5 months

One year ago today, we introduced Chroma, our generative AI model that creates novel proteins on-demand. Since then, we’ve entered an era of generative biology where proteins can be tailored to the specifics of any problem. Learn more:

0

2

18

Generate:Biomedicines

@generate_biomed

2 years

What if you could design a ‘de novo’ protein, a protein that does not exist in nature, that could bind to a specific target with specific properties? Yesterday at #CodeCon , @NoubarAfeyan shared how Generate is doing just that. We are making the previously impossible, possible.

Flagship Pioneering

@FlagshipPioneer

2 years

1/4 Flagship’s Founder & CEO, @NoubarAfeyan , shares the stage with @KaraSwisher at #CodeCon to discuss how Flagship and our ecosystem of companies like @Generate_Biomed are leading the way in the greatest improvement in the human condition since the discovery of #DNA . @voxmedia

1

3

10

1

16

Generate:Biomedicines

@generate_biomed

4 months

Kicking off the year with key clinical updates: first patient dosed with GB-0895 for mild-to-moderate asthma and advancement in our GB-0669 study for SARS-CoV-2. We’ve also expanded our relationship with @Amgen to push the boundaries of drug development.

0

2

17

Generate:Biomedicines

@generate_biomed

3 years

We're building a team that will fundamentally change the way medicines are brought to the world. Interested? Generate new ideas with us. #biotechjobs

1

9

16

Generate:Biomedicines

@generate_biomed

2 years

We were one of only five pharma companies to be named on this list this year. Congrats to our whole team for the work they have done to advance our innovative #generativebiology platform. #machinelearning #AI

0

1

14

Generate:Biomedicines

@generate_biomed

1 year

Read the article from @Analyticsindiam and learn how our #ML model Chroma gives us the ability to generate novel proteins, and generate them towards desired biological functions - developing proteins in a controlled fashion for targets that others cannot. #ProteinEngineering

Analytics India Magazine

@Analyticsindiam

1 year

Boston-based therapeutics company @generate_biomed announced a program called Chroma which, according to the company, is the “DALL-E 2 of biology.” #ai #generativeai #proteinstructure #chroma #dalle #texttoimage #aigenerators #news #technews

1

4

6

0

4

15

Generate:Biomedicines

@generate_biomed

4 months

Dive into the cutting-edge world of generative AI with our CTO & Co-Founder @ggrigoryanv in an upcoming episode of @VantAI ’s Generative AI in Drug Discovery series. Join @mmbronstein and @befcorreia as they gain expert perspective on the role of this technology in drug discovery.

VantAI

@vant_ai

5 months

📣 Join us for @generate_biomed 's @ggrigoryanv talk on "Chroma: Illuminating protein space with a programmable generative model”, recently published in Nature, at the GenAI series hosted by @mmbronstein and @befcorreia ! 📅 Jan 19, 2024; 11am ET / 5pm CET / 8am PST 🔗 Register for…

0

10

30

0

6

17

Generate:Biomedicines

@generate_biomed

3 years

We were excited to collaborate with the @gatesfoundation to help map the functional/neutralizing landscape of SARS CoV-2 antibodies. Learn more:

Defining variant-resistant epitopes targeted by SARS-CoV-2 antibodies: A global consortium study

SARS-CoV-2 spike antibodies in three distinct epitope communities retain activity against SARS-CoV-2 variants.

www.science.org

0

5

14

Generate:Biomedicines

@generate_biomed

2 years

We're excited to share the first in a series of thought leadership articles. This one comes to you from @gibsmk , @AndrewLBeam , and Gevorg Grigoryan. Stay tuned for part 2 in this series and more articles on additional topics in the coming weeks and months

Part I: Extracting the Hidden Principles of Biology with Machine Learning

By Andrew Beam, Ph.D.

www.linkedin.com

0

2

14

Generate:Biomedicines

@generate_biomed

2 years

Hear from our co-founder and board member @GVMaltzahn about how our #GenerativeBiology technology platform could change the #future of therapeutic development.

0

1

15

Generate:Biomedicines

@generate_biomed

1 year

Great interview by @strwbilly with our CTO, @ggrigoryanv , about our #ML model, Chroma, and the exciting advances being made in #proteinengineering . These advances are bringing us closer to delivering better and more effective medicines to patients faster than ever before.

MIT Technology Review

@techreview

1 year

New: Two groups have announced powerful new generative models that can create new proteins not seen in nature on demand.

2

25

48

0

2

14

Generate:Biomedicines

@generate_biomed

1 year

We're incredibly thankful and proud of our #GenerateTeam , who stepped up to help address housing instability and food insecurity in our local #community this #Thanksgiving . Because of their generosity, we were able to raise over $16K and donate two carloads of food. #GivingBack

0

13

Generate:Biomedicines

@generate_biomed

2 years

We believe biology will be the next industrial revolution. Interesting thought, right? If you’d like to hear more about it, then vote for us to participate in a panel discussion at #SXSW2023 at .

0

2

12

Generate:Biomedicines

@generate_biomed

2 years

We hit an exciting milestone - we have grown to more than 200 employees! We're thrilled to be building such a diverse and exciting team of Generators. If you're interested in changing the way new medicines are created, check out our open positions.

0

12

Generate:Biomedicines

@generate_biomed

1 year

On Wednesday, Yue Liu will be speaking at the @SLAS_Org 2023 International Conference & Exhibition. Hear her presentation about our integrated wet & dry lab capabilities & how we're using high-throughput assay data to optimize the function of ML-driven antibody design. #SLAS2023

0

2

12

Generate:Biomedicines

@generate_biomed

2 years

Recently our Generators came together to work with Project SOUP in our local community, #SomervilleMA to make grocery delivery bags for families in need. Thanks to Ali Bootwala for helping to spearhead our effort.

0

1

12

Generate:Biomedicines

@generate_biomed

1 year

During JPM, cross-industry leaders discussed the scalability of AI and how it can solve productivity challenges. Our CEO, @mike_nally shares how we're turning biological problems into digital problems, creating the capacity to engineer optimal health outcomes.

Flagship Pioneering

@FlagshipPioneer

1 year

Industry experts from @MSFTResearch , @nvidia , @McKinsey , and #FlagshipFounded @generate_biomed join Flagship’s Armen Mkrtchyan to discuss the massive role that #AI is playing in charting the future of #biotech and healthcare. Watch:

1

2

10

0

2

12

Generate:Biomedicines

@generate_biomed

2 years

Today @NoubarAfeyan will speak at #codecon where he will discuss how Generate Biomedicines is going to revolutionize the future of #drugdevelopment through #generativebiology .

Noubar Afeyan

@NoubarAfeyan

2 years

Last minute prep for my talk about code-based medicines at #codecon . Open to tips on being interviewed by @karaswisher .... @Recode

4

7

72

0

1

12

Generate:Biomedicines

@generate_biomed

1 year

With new #COVID variants emerging and uncertainty about effective therapies, @g0ingmad at @business talks about the need for a new treatment approach. At Generate, we are doing just that. We’re using #AI to develop a more potent antibody and plan to submit our first IND in 2023.

Bloomberg

@business

1 year

With each new round of Covid mutations, some antibody drugs have lost effectiveness and been pulled from the market. It’s quite possible doctors will soon have none left to choose from

1

12

15

1

6

12

Generate:Biomedicines

@generate_biomed

1 year

Wondering how our #ML model Chroma can create new proteins & protein complexes given geometric & functional constraints? Read the latest from @freethinkmedia on how it learns to transform unstructured, random 3D shapes into large and complex proteins. #ProteinEngineering #AI

Freethink

@freethinkmedia

1 year

Boston-based startup @generate_biomed is further advancing our understanding and use of proteins by training an AI called “Chroma” to create proteins with structures no one has ever seen before.

0

2

4

1

2

12

Generate:Biomedicines

@generate_biomed

2 years

Thank you to our first class of Ph.D. machine learning interns. Last week they presented their summer research to help the development of new kinds of #MachineLearning systems for protein therapeutic design. A special thanks to their Generate mentors. #proteinbiology

0

2

11

Generate:Biomedicines

@generate_biomed

1 year

We're thrilled to announce the appointment of Beth Grous as Chief People Officer. Beth will help build Generate’s HR function and champion people strategies across the business. Read more about the appointment and Beth's extensive leadership experience:

0

12

Generate:Biomedicines

@generate_biomed

1 year

Live from #JPM23 : Our CEO, @mike_nally , discussed with @FlagshipPioneer how we're revolutionizing drug discovery and development through our machine learning capabilities, and how the mindsets of our team support our fiercely united culture.

Flagship Pioneering

@FlagshipPioneer

1 year

Mike Nally, CEO of @generate_biomed , explains how the company is leveraging computation to accelerate the pace of drug discovery and development. More from his interview at #JPM23 here: #FlagshipJPM

1

7

0

1

12

Generate:Biomedicines

@generate_biomed

2 years

It’s great to be recognized for the potential of our platform to create entirely novel, de novo proteins that are specifically generated to address therapeutic needs. @fastcompany

0

3

10

Generate:Biomedicines

@generate_biomed

1 year

On May 15, our CTO @ggrigoryanv will join fellow innovators at the @awscloud Life Sciences Executive Symposium to share how Generate is making biology engineerable.

0

1

12

Generate:Biomedicines

@generate_biomed

1 year

As active members of our community, we're cheering on colleagues running today's @BostonMarathon . Sean Martin and Tyson Fetzer will run to support causes they're passionate about, and when Lisa Wyman finishes, she'll be one of only 19 people to complete 22 consecutive marathons!

0

4

12

Generate:Biomedicines

@generate_biomed

3 years

At Generate Biomedicines, we are focused on more than just #science . We're also generating connections. Our team set out on the Charles River for some kayaking and team building. #TogetherWeGenerate #TeamGenerate

0

1

12

Generate:Biomedicines

@generate_biomed

1 year

Our own @gibsmk and Jason Silvers attended today's @Nasdaq opening bell ringing to celebrate the start of the 41st Annual @jpmorgan Healthcare Conference. Watch the live broadcast: #TeamGenerate #JPM23

0

2

12

Generate:Biomedicines

@generate_biomed

2 years

Interested in working w/ one of the leading minds at the intersection of protein design, #computationalbiology , and ML? We're looking for a Head of #DataScience and Head of Computational #Protein Generation.

0

3

12

Generate:Biomedicines

@generate_biomed

1 year

We're pleased to expand our leadership team and welcome Dimitris Agrafiotis as Chief Digital Officer. Dimitris will help us as we expand and scale our technology and #generativebiology platform. Read more: #TeamGenerate

0

3

11

Generate:Biomedicines

@generate_biomed

2 years

As we continue to grow, we’re expanding our leadership team with the addition of former Merck executive, Dr. Alex Snyder and former Goldman Sachs co-head of EMEA healthcare investment banking, Dr. Jason Silvers. Read more here

0

9

Generate:Biomedicines

@generate_biomed

2 years

Generate is turning 4! It's been 4 years since Generate began pioneering the field of #generativebiology - a revolutionary approach to #drugdevelopment that allows us to program protein-based modalities for the first time. #TeamGenerate

0

11

Generate:Biomedicines

@generate_biomed

1 year

@NatureBiotech gives an overview of the use of ML & generative models for protein design, including our model Chroma. @ggrigoryanv shares insights about our algorithmic toolbox & how our CryoEM facility is a critical component to developing therapeutics.

AI-enhanced protein design makes proteins that have never existed

Nature Biotechnology - Protein engineers are drawing on rapidly evolving machine learning tools, deep reservoirs of data, and the structure-predicting firepower of AlphaFold2 to pursue more...

www.nature.com

0

2

10

Generate:Biomedicines

@generate_biomed

2 years

We enjoyed coming together and celebrating our passion for collaboratively inventing and innovating during our inaugural Science Day. Our #GenerateTeam brought forward more than 60 posters, and we spent the day engaging in meaningful discussions about #AI and #drugdiscovery .

0

2

11

Generate:Biomedicines

@generate_biomed

1 year

#DYK there is a 90% failure rate in drug development? Our Co-Founder and CIO, @gibsmk , shares how with #AI we are no longer predicting biology, but rather generating new biology which will help us develop faster, better, and more affordable therapeutics:

‘We can invent new biology’: Molly Gibson on the power of AI

The cofounder of Generate Biomedicines, a pioneering new drug development platform, describes how AI and machine learning are transforming the way we discover new medicines.

www.mckinsey.com

0

1

11

Generate:Biomedicines

@generate_biomed

8 months

Daniel Leventhal, our Head of Immunogenicity, will deliver a keynote at the Next Generation Protein Therapeutics Summit on how generative AI is used to engineer therapeutic enzymes to evade unwanted immunogenicity.

0

3

11

Generate:Biomedicines

@generate_biomed

8 months

We recently wrapped up our Machine Learning Summer Internship Program, where five ambitious grad students helped advance our ML technologies for therapeutic design. We’re grateful for their talents, creativity, and sense of fun while we worked towards improving human health.

0

1

11

Generate:Biomedicines

@generate_biomed

6 months

Through our new collaboration with @RoswellPark , we aim to harness the power of The Generate Platform to discover & develop chimeric antigen receptor (CAR) T-cell therapies and armoring technologies for up to three oncology targets. Learn more:

0

2

10

Generate:Biomedicines

@generate_biomed

2 years

Jason Silvers’ deep financial expertise, especially his strategic and transactional experience with Goldman Sachs, will help Generate advance into its next stage of growth. Learn more:

0

10

Generate:Biomedicines

@generate_biomed

8 months

@bradloncar of @BiotechTVHQ visited Boynton Yards to talk w/ our CEO @mike_nally about the transition for our industry as biology becomes engineerable. As Mike says, “when you start to program medicines, you change probabilities, speed and you change quality all at once.”

BiotechTV

@BiotechTVHQ

8 months

Company news: Generate Biomedicine’s CEO Mike Nally on Thursday’s $273M Series C and computational drug development. Full video:

0

4

13

1

3

10

Generate:Biomedicines

@generate_biomed

1 year

Want to know how Generate is using #AI to revolutionize #drugdiscovery ? Our Co-Founder and CTO will join distinguished thought leaders in a panel discussion at the @BioCentury -BayHelix East-West Biopharma Summit. #BioCenturyEastWest #MachineLearning #ProteinEngineering

0

1

10

Generate:Biomedicines

@generate_biomed

2 years

Proud of our colleagues Alexandra Snyder & Dinesh De Alwis for their commentary published today in @NatureMedicine on the impact of clinical holds on smaller biotechs and how they ultimately benefit patients by leading to better medicines.

0

3

10

Generate:Biomedicines

@generate_biomed

8 months

We are honored to be recognized as one of @DrugDiscoverDev ’s 30 biotech startups making waves. Read more:

30 biotech startups leading in pharmaceutical innovation

Spotlight on Pionyr, ADARx, Orna Therapeutics and more as 30 biotech startups aim to redefine drug discovery, development and more.

www.drugdiscoverytrends.com

0

1

10

Generate:Biomedicines

@generate_biomed

4 months

Generative AI is capturing the spotlight at the @JPMorgan Healthcare Conference, and we’re at the forefront with our expanded collaboration with @Amgen . Read more in an interview with our CEO @mike_nally by @GrinsteinJ of @GENbio .

Genetic Engineering & Biotechnology News

@GENbio

4 months

Amgen Opts-in on Generate:Biomedicines Collaboration for Drug Development Amgen will make an undisclosed upfront payment and will pay up to $370 million in future milestones and royalties up to double digits for this new program. Learn more:

0

1

8

1

2

10

Generate:Biomedicines

@generate_biomed

1 year

Check out our relentlessly curious junior generators who joined us for Bring Your Child to Work Day. We had plenty of experiments ready to get our children thinking like scientists and engineers – as these are our future leaders in STEM.

0

10

Generate:Biomedicines

@generate_biomed

5 months

Check out today’s @cenmag article by @LaurelOld spotlighting the capabilities of Chroma, our open-source generative AI model used to design new therapeutics:

Chemistry in Pictures: Alpha-helical alphabet

Serving the chemical, life science, and laboratory worlds

cen.acs.org

0

9

Generate:Biomedicines

@generate_biomed

1 year

Congratulations to our own Sean Martin for his nomination to the 2022 Irish Legal 100, an annual compilation of the most distinguished legal professionals of Irish descent in the U.S. Check out his story as a fifth-generation Irish attorney:

0

9

Generate:Biomedicines

@generate_biomed

1 year

Tomorrow, our Chief Medical Officer, Alex Snyder, will be presenting her latest #oncology research at the @sitcancer annual meeting. Watch her presentation describing post-progression response to checkpoint inhibitors in patients treated beyond progression. #SITC2022

0

1

9

Generate:Biomedicines

@generate_biomed

2 years

Our Co-Founder & Chief Strategy and Innovation Officer @gibsmk sat down with #Wharton MBA student-run podcasters at LifeSci Beat. To hear their conversation listen in

1

0

9

Generate:Biomedicines

@generate_biomed

1 year

Check out the story from @RLCscienceboss describing how we are using #AI to generate and experimentally validate novel proteins. Learn about our latest advances in #ProteinEngineering in this interview with our CEO @mike_nally and CTO @ggrigoryanv .

Ryan Cross the Science Boss

@RLCscienceboss

1 year

The de novo protein design field is heating up. My story for the @BostonGlobe on preprints from @FlagshipPioneer startup @generate_biomed and David Baker's group at @UWproteindesign using an A.I. method that powers DALL-E to create new proteins.

1

22

115

0

1

9

Generate:Biomedicines

@generate_biomed

2 years

#ICYMI Interested in learning more about Generate? Our CEO, @mike_nally gave an on-demand showcase presentation at the @GENbio "state of Biotech" conference. Watch the replay here:

0

9

Generate:Biomedicines

@generate_biomed

3 years

"The technology of yesterday's science fiction is quietly becoming the reality of this moment. How?" CEO @Mike_Nally explains what medicine will look like in the post-COVID world of tomorrow – and how companies like Generate are leading the way.

The Future of Medicine Is in Artificial Intelligence

The industry has reached a point at which self-learning computers can truly transform how we cure diseases, fight cancer and develop groundbreaking new drugs – at higher quality and lower price...

morningconsult.com

0

3

9

Generate:Biomedicines

@generate_biomed

9 months

We’re honored to be nominated for “Best Startup” by the @GalienFdn Prix Galien USA Awards. Recognitions like these reflect our relentless pursuit to revolutionize drug discovery & development using generative AI. Congratulations to Team Generate.

The Galien Foundation

@GalienFdn

9 months

The Galien Foundation is delighted to announce the 2023 #PrixGalien USA Awards nominees for “Best Digital Health Solution," “Best Medical Technology,” "Incubators, Accelerators and Equity," and "Best Startup". Full list available here:

2

4

13

0

2

9

Generate:Biomedicines

@generate_biomed

2 years

#TeamGenerate recently hosted grad students from the @UChicago ’s myCHOICE program, which seeks to expose biological science trainees to an array of career opportunities. Together with @TesseraTx , we provided a campus tour and hosted a panel discussion with members of leadership.

0

9

Generate:Biomedicines

@generate_biomed

2 years

Alexandra Snyder’s significant clinical experience will help guide Generate’s development program as we pioneer generative biology.

0

1

8

Generate:Biomedicines

@generate_biomed

1 year

What do biotech entrepreneurs need to know as they plan to scale their ventures? Our Co-Founder Molly Gibson will answer this question and more at the @MassBio Align Summit – sharing lessons learned from scaling biotech companies, including Generate.

0

4

9

Generate:Biomedicines

@generate_biomed

1 year

#TeamGenerate is constantly looking at ways to #giveback and help our local #community . With the holidays being a season of giving, we're excited to support @somrvillefridge by providing a weekly food donation to help fight #foodinsecurity . #HappyHolidays

0

8

Generate:Biomedicines

@generate_biomed

1 year

With 86% of drug development programs ending in failure and estimates of up to several billion dollars to bring a drug to market - @ChemistryWorld highlights how companies are tackling these challenges with AI. Read about our unique computational approach:

Encoding creativity in drug discovery

Machine learning can complement and reinforce human intuition and experience

www.chemistryworld.com

0

1

9

Generate:Biomedicines

@generate_biomed

1 year

We’re honored to be recognized by the @bioitworld ’s 2023 Innovative Practice Awards for our efforts to revolutionize drug discovery and development using The Generate Platform. Congratulations to the Generate team for this achievement.

0

9

Generate:Biomedicines

@generate_biomed

8 months

5 years. 5 perspectives from founding to future. Inspired by our 5th anniversary, hear Team Generate offer their unique take on the generative biology revolution. Check out CEO @mike_nally 's thoughts below and follow along as we share new perspectives each week.

0

9

Generate:Biomedicines

@generate_biomed

2 years

Our very own @gibsmk will join other industry leaders tomorrow for a panel discussion about the role of #AI and #ML in drug discovery and development at the @FierceBiotech Summit. Check out the agenda here:

0

1

9

Generate:Biomedicines

@generate_biomed

2 years

Congratulations #GenerateTeam on being named to the Endpoints11! We are proud to be part of the 2022 list which highlights the most promising private biotechs in the industry. #generativebiology #FlagshipFounded @endpts

0

2

9